InsidersTradesSigma
Track the 千红制药 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 千红制药 has recorded 6 public disclosures. Market capitalisation: €8.7bn. The latest transaction was disclosed on 29 May 2025 (Sale). Among the most active insiders: 王轲. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€10m
2 ops.
Buy Volume
€5m
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,477 of 29,064 companies
65.5
score / 100
Value49
Quality82
FCF yld2.5%
Earn yld4.6%
EV/EBITDA16.9x
ROE11%
Gross mgn58%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 May 2025
Declarations6 total
6 of 6 declarations
Acerca de 千红制药
千红制药 es una empresa especializada en el sector de la salud y farmacéutico, que ofrece una gama de productos farmacéuticos. Cotiza en el mercado XSHE.